Navigation Links
Med-Tek Launches the First Evidenced Based Opioid Management Program (OMP)

COCONUT GROVE, Fla., April 9, 2012 /PRNewswire/ --Med-Tek a developer of Healthcare Technology Networks ("HTN") designed to improve outcomes for patients, physicians, employers and their constituents today announces the launch of its proprietary Opioid Management Program (OMP).

According to the United States Bone & Joint Decade, from 2002 through 2004 individuals suffering from musculoskeletal disease filled 1.6 billion prescriptions. While 18.6 is the mean number of prescriptions filled per person, 83.5% of sufferers only filled a single prescription.(1) These staggering figures combined with often publicized concerns including lethal overdose, addiction, elongated claim durations and ever-increasing costs, has driven the workers' compensation industry to seek out more effective means to manage opioid dosing practices.

Tom B. Leamon, Ph.D., Med-Tek Board Member and former Vice President, Director of the Liberty Mutual Research Institute for Safety stated "given the amount of research on the magnitude of the issues associated with opioid abuse in the occupational and non-occupational settings, an evidence-based solution directly impacting the root of the problem is far overdue".

When diagnosing and treating Soft Tissue Injuries (STIs) - including dispensing of opioids - practitioners in both the work and non-work arenas have not historically been afforded benefits generated by scientifically validated data. With OMP, in addition to corroborating subjective patient complaints, the existence of acute pathology can be quantified.

"Medical professionals with OMP in their arsenal will have access to empirical data augmenting their clinical expertise. Furthermore, yielding even better results, care management tools employed by carriers, Pharmacy Benefit Managers (PBMs), Third Party Administrators (TPAs) as well as managed care providers can be applied in the right instances and at the right time" said Kerwin Williams, Med-Tek's Senior Vice President.

About Med-Tek

Med-Tek deploys Healthcare Technology Networks ("HTN") impacting inefficiencies in overall patient care. Through objective clinically validated data pertaining to soft tissue pathologies and injuries, clinically validated data generates unmatched synergistic efficiencies resulting in a fundamental shift in the global healthcare economy.

For more information on Med-Tek's OMP contact:

Kerwin Williams
Senior Vice President
Med-Tek, LLC
2665 S. Bayshore Dr., 5th FL
Coconut Grove, FL 33133
Office: 866-930-2627  ext. 121

1. United States Bone & Joint Decade: The Burden of Musculoskeletal Diseases in the United States. Rosemont IL, American Academy of Orthopedic Surgeons 2011


Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
2. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
3. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
4. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
7. Premier Micronutrient Launches Supplement for Hearing Health
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
11. Launches STD Social Networking Site Balancing Dating with Online Support Features
Post Your Comments:
(Date:12/1/2015)... -- CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical ... that it has reached its enrollment target of 400 ... trial of aldoxorubicin in patients with previously treated soft ... in Q1 2016. The Phase 3 trial is a randomized, ... from the FDA at 79 sites in ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
(Date:12/1/2015)... , Dec. 1, 2015  Booth #3506 – Claymount is ... the annual meeting of the Radiological Society of ... this year. Based in the Netherlands ... Varian Medical Systems (NYSE: VAR ) and is one ... chambers and solid state automatic exposure control systems for controlling ...
Breaking Medicine Technology:
(Date:12/1/2015)... , ... December 01, 2015 , ... ... 1980s we have seen vast improvements in scientific research and discoveries, leading us ... providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition ...
(Date:12/1/2015)... ... December 01, 2015 , ... The ... been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s first portable ... Meeting from November 29 to December 4, 2015. , MED-TAB is expected ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... San Francisco, CA (PRWEB) , ... December 01, ... ... The Behavioral Health Center of Excellence (BHCOE) today announced that the organization has ... based in San Francisco, with a Distinguished Award. The award celebrates exceptional special ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, ... in the United States. Clarity is a Superior Dual Wavelength Platform which combines ... single platform that is easy to own and operate. , For over a ...
Breaking Medicine News(10 mins):